Literature DB >> 22302890

The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers.

G C Harborne1, F L Watson, D T Healy, L Groves.   

Abstract

The cognitive and subjective effects of sub-anaesthetic doses of ketamine on healthy volunteers were examined. Twelve healthy volunteers received 25 mg ketamine, 10 mg ketamine and saline placebo, i.m. in a double-blind, Latin square design. A cognitive, perceptual and self-report test battery was administered over 45 min. The order of tests was rotated to control for timing effects. Ketamine (25 mg) significantly affected verbal learning and memory, parallel visual search, some measures of psychomotor performance, measures of arousal, subjective mood ratings and visual perception. Measures of attention and frontal lobe functioning were relatively unaffected. Thus, low doses of ketamine had selective, dose-related effects on memory, perceptual and psychomotor functions. The disruption of memory and perceptual processes may help to explain the unique subjective state induced by ketamine.

Entities:  

Year:  1996        PMID: 22302890     DOI: 10.1177/026988119601000208

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  12 in total

1.  Subtle effects of ketamine on memory when administered following stimulus presentation.

Authors:  David J LaPorte; Teresa A Blaxton; Tamara Michaelidis; Donald U Robertson; Martin A Weiler; Carol A Tamminga; Adrienne C Lahti
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

2.  The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.

Authors:  J P van der Post; S J de Visser; M L de Kam; M Woelfler; D C Hilt; J Vornov; E S Burak; E Bortey; B S Slusher; T Limsakun; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

3.  Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.

Authors:  Valerio Ricci; Giovanni Martinotti; Francesca Gelfo; Federico Tonioni; Carlo Caltagirone; Pietro Bria; Francesco Angelucci
Journal:  Psychopharmacology (Berl)       Date:  2010-12-14       Impact factor: 4.530

Review 4.  Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-10

Review 5.  Acute and chronic effects of ketamine upon human memory: a review.

Authors:  Celia J A Morgan; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-09-28       Impact factor: 4.530

6.  The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.

Authors:  Arti Parwani; Martin A Weiler; Teresa A Blaxton; Dale Warfel; Michael Hardin; Kristin Frey; Adrienne C Lahti
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study.

Authors:  Celia J A Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

8.  Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.

Authors:  Rebekah A E Honey; Danielle C Turner; Garry D Honey; Sam R Sharar; D Kumaran; E Pomarol-Clotet; P McKenna; B J Sahakian; T W Robbins; P C Fletcher
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

9.  Temporal dynamics of distinct CA1 cell populations during unconscious state induced by ketamine.

Authors:  Hui Kuang; Longnian Lin; Joe Z Tsien
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

10.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.